The company has started working on new projects:

• Our company signed a contract for three modules of the registration dossier preparation for a Russian company.
• Smooth reached an agreement with a global company for research report adaptation for a publication and data processing and medical writing for a current study.
• Our company was awarded organization and research for the Phase I study of INN: Fabomotizole.
• Smooth is concluding an agreement for data processing and medical writing for Phase I
• study of INN: Adalimumab.
• Smooth was awarded to conduct a Phase I trial in hepatology.
• Our company is signing an agreement for pharmacovigilance of 12 marketed products with an international company.
• Our company was awarded a phase III trial in endometriosis by a European company.

• In November our clinical team has closed all sites in a European study in hepatology.
• Smooth submitted international phase III study in schizophrenia to the Russian and Ukrainian MoHs.
• MoH granted approval to a phase I-II study in AML.